"World's Most Complete Market Research Reports Repository"

Global Oncology Biosimilars Market Professional Survey Report 2018

This report studies the global Oncology Biosimilars market status and forecast, categorizes the global Oncology Biosimilars market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, India, Southeast Asia and other regions (Central & South America, and Middle East & Africa).

Oncology biosimilars are similar versions of oncology biologics that are manufactured by different companies and have been officially approved for cancer treatment. Biosimilars are cost-effective molecules with the same efficacy and potency as the original reference biologic. The relatively easy manufacturing of biosimilars and the license to manufacture biosimilars after the expiration of original reference biologic is acting in favor of the global oncology biosimilars market.
Cancer represents a massive burden on healthcare systems worldwide due to the high cost of treatment therapeutics. The patent expiry of several cancer therapeutics has allowed the entry of biosimilars, which are being incorporated into oncology treatment practices. Biosimilars are synthesized with the use of biologic components such as monoclonal antibodies, proteins, hormones, nucleic acids, colony stimulating factors, interleukins, and enzymes. The market offers huge growth opportunities for vendors because of the growing incidence of cancer. The clinical pipeline for cancer biosimilars is vast, featuring candidates in different stages of development. Around 30% of all the biosimilars that are awaiting the US FDA?s approval are monoclonal antibodies, including biosimilars of Avastin, MabThera, and Herceptin.
Factors like the arrival of new biosimilars to drive market growth during the forecast period. Unlike generic drugs, which have APIs that are identical to original drugs, biosimilars are similar to their originator biologic compounds. Biosimilars developed by different manufacturers differ from the original product as well as from each other. Since they are less expensive than biologics, patients will be able to afford and access biosimilars more easily than biologics. Rise in number of patent expiries, increase in prevalence of cancer, growing aging population, promising drug pipeline, need for cost-effective treatment, favorable government regulations are some of the key drivers promoting the growth of oncology biosimilars market.
The global Oncology Biosimilars market is valued at xx million US$ in 2017 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2018-2025.

The major manufacturers covered in this report
Biocon
Celltrion
Dr Reddy's Laboratories
F Hoffmann-La Roche
Mylan
Sandoz
...

Geographically, this report studies the top producers and consumers, focuses on product capacity, production, value, consumption, market share and growth opportunity in these key regions, covering
North America
Europe
China
Japan
India
Southeast Asia
Other regions (Central & South America, Middle East & Africa)

We can also provide the customized separate regional or country-level reports, for the following regions:
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Rest of Asia-Pacific
Europe
Germany
France
UK
Italy
Spain
Russia
Rest of Europe
Central & South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Saudi Arabia
Turkey
Rest of Middle East & Africa

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Breast Cancer
Blood Cancer
Colorectal Cancer
Non-Small
Cell Lung Cancer
Neutropenia
Others

By Application, the market can be split into
Retail Pharmacies
Hospitals

The study objectives of this report are:
To analyze and study the global Oncology Biosimilars capacity, production, value, consumption, status (2013-2017) and forecast (2018-2025);
Focuses on the key Oncology Biosimilars manufacturers, to study the capacity, production, value, market share and development plans in future.
Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
To define, describe and forecast the market by type, application and region.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends and factors driving or inhibiting the market growth.
To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Oncology Biosimilars are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders
Oncology Biosimilars Manufacturers
Oncology Biosimilars Distributors/Traders/Wholesalers
Oncology Biosimilars Subcomponent Manufacturers
Industry Association
Downstream Vendors

Available Customizations
With the given market data, QYResearch offers customizations according to the company's specific needs. The following customization options are available for the report:
Regional and country-level analysis of the Oncology Biosimilars market, by end-use.
Detailed analysis and profiles of additional market players.

Table of Contents

Global Oncology Biosimilars Market Professional Survey Report 2018
1 Industry Overview of Oncology Biosimilars
1.1 Definition and Specifications of Oncology Biosimilars
1.1.1 Definition of Oncology Biosimilars
1.1.2 Specifications of Oncology Biosimilars
1.2 Classification of Oncology Biosimilars
1.2.1 Breast Cancer
1.2.2 Blood Cancer
1.2.3 Colorectal Cancer
1.2.4 Non-Small
1.2.5 Cell Lung Cancer
1.2.6 Neutropenia
1.2.7 Others
1.3 Applications of Oncology Biosimilars
1.3.1 Retail Pharmacies
1.3.2 Hospitals
1.4 Market Segment by Regions
1.4.1 North America
1.4.2 Europe
1.4.3 China
1.4.4 Japan
1.4.5 Southeast Asia
1.4.6 India

2 Manufacturing Cost Structure Analysis of Oncology Biosimilars
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Oncology Biosimilars
2.3 Manufacturing Process Analysis of Oncology Biosimilars
2.4 Industry Chain Structure of Oncology Biosimilars

3 Technical Data and Manufacturing Plants Analysis of Oncology Biosimilars
3.1 Capacity and Commercial Production Date of Global Oncology Biosimilars Major Manufacturers in 2017
3.2 Manufacturing Plants Distribution of Global Oncology Biosimilars Major Manufacturers in 2017
3.3 R&D Status and Technology Source of Global Oncology Biosimilars Major Manufacturers in 2017
3.4 Raw Materials Sources Analysis of Global Oncology Biosimilars Major Manufacturers in 2017

4 Global Oncology Biosimilars Overall Market Overview
4.1 2013-2018E Overall Market Analysis
4.2 Capacity Analysis
4.2.1 2013-2018E Global Oncology Biosimilars Capacity and Growth Rate Analysis
4.2.2 2017 Oncology Biosimilars Capacity Analysis (Company Segment)
4.3 Sales Analysis
4.3.1 2013-2018E Global Oncology Biosimilars Sales and Growth Rate Analysis
4.3.2 2017 Oncology Biosimilars Sales Analysis (Company Segment)
4.4 Sales Price Analysis
4.4.1 2013-2018E Global Oncology Biosimilars Sales Price
4.4.2 2017 Oncology Biosimilars Sales Price Analysis (Company Segment)

5 Oncology Biosimilars Regional Market Analysis
5.1 North America Oncology Biosimilars Market Analysis
5.1.1 North America Oncology Biosimilars Market Overview
5.1.2 North America 2013-2018E Oncology Biosimilars Local Supply, Import, Export, Local Consumption Analysis
5.1.3 North America 2013-2018E Oncology Biosimilars Sales Price Analysis
5.1.4 North America 2017 Oncology Biosimilars Market Share Analysis
5.2 Europe Oncology Biosimilars Market Analysis
5.2.1 Europe Oncology Biosimilars Market Overview
5.2.2 Europe 2013-2018E Oncology Biosimilars Local Supply, Import, Export, Local Consumption Analysis
5.2.3 Europe 2013-2018E Oncology Biosimilars Sales Price Analysis
5.2.4 Europe 2017 Oncology Biosimilars Market Share Analysis
5.3 China Oncology Biosimilars Market Analysis
5.3.1 China Oncology Biosimilars Market Overview
5.3.2 China 2013-2018E Oncology Biosimilars Local Supply, Import, Export, Local Consumption Analysis
5.3.3 China 2013-2018E Oncology Biosimilars Sales Price Analysis
5.3.4 China 2017 Oncology Biosimilars Market Share Analysis
5.4 Japan Oncology Biosimilars Market Analysis
5.4.1 Japan Oncology Biosimilars Market Overview
5.4.2 Japan 2013-2018E Oncology Biosimilars Local Supply, Import, Export, Local Consumption Analysis
5.4.3 Japan 2013-2018E Oncology Biosimilars Sales Price Analysis
5.4.4 Japan 2017 Oncology Biosimilars Market Share Analysis
5.5 Southeast Asia Oncology Biosimilars Market Analysis
5.5.1 Southeast Asia Oncology Biosimilars Market Overview
5.5.2 Southeast Asia 2013-2018E Oncology Biosimilars Local Supply, Import, Export, Local Consumption Analysis
5.5.3 Southeast Asia 2013-2018E Oncology Biosimilars Sales Price Analysis
5.5.4 Southeast Asia 2017 Oncology Biosimilars Market Share Analysis
5.6 India Oncology Biosimilars Market Analysis
5.6.1 India Oncology Biosimilars Market Overview
5.6.2 India 2013-2018E Oncology Biosimilars Local Supply, Import, Export, Local Consumption Analysis
5.6.3 India 2013-2018E Oncology Biosimilars Sales Price Analysis
5.6.4 India 2017 Oncology Biosimilars Market Share Analysis

6 Global 2013-2018E Oncology Biosimilars Segment Market Analysis (by Type)
6.1 Global 2013-2018E Oncology Biosimilars Sales by Type
6.2 Different Types of Oncology Biosimilars Product Interview Price Analysis
6.3 Different Types of Oncology Biosimilars Product Driving Factors Analysis
6.3.1 Breast Cancer Growth Driving Factor Analysis
6.3.2 Blood Cancer Growth Driving Factor Analysis
6.3.3 Colorectal Cancer Growth Driving Factor Analysis
6.3.4 Non-Small Growth Driving Factor Analysis
6.3.5 Cell Lung Cancer Growth Driving Factor Analysis
6.3.6 Neutropenia Growth Driving Factor Analysis
6.3.7 Others Growth Driving Factor Analysis

7 Global 2013-2018E Oncology Biosimilars Segment Market Analysis (by Application)
7.1 Global 2013-2018E Oncology Biosimilars Consumption by Application
7.2 Different Application of Oncology Biosimilars Product Interview Price Analysis
7.3 Different Application of Oncology Biosimilars Product Driving Factors Analysis
7.3.1 Retail Pharmacies of Oncology Biosimilars Growth Driving Factor Analysis
7.3.2 Hospitals of Oncology Biosimilars Growth Driving Factor Analysis

8 Major Manufacturers Analysis of Oncology Biosimilars
8.1 Biocon
8.1.1 Company Profile
8.1.2 Product Picture and Specifications
8.1.2.1 Product A
8.1.2.2 Product B
8.1.3 Biocon 2017 Oncology Biosimilars Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.1.4 Biocon 2017 Oncology Biosimilars Business Region Distribution Analysis
8.2 Celltrion
8.2.1 Company Profile
8.2.2 Product Picture and Specifications
8.2.2.1 Product A
8.2.2.2 Product B
8.2.3 Celltrion 2017 Oncology Biosimilars Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.2.4 Celltrion 2017 Oncology Biosimilars Business Region Distribution Analysis
8.3 Dr Reddy's Laboratories
8.3.1 Company Profile
8.3.2 Product Picture and Specifications
8.3.2.1 Product A
8.3.2.2 Product B
8.3.3 Dr Reddy's Laboratories 2017 Oncology Biosimilars Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.3.4 Dr Reddy's Laboratories 2017 Oncology Biosimilars Business Region Distribution Analysis
8.4 F Hoffmann-La Roche
8.4.1 Company Profile
8.4.2 Product Picture and Specifications
8.4.2.1 Product A
8.4.2.2 Product B
8.4.3 F Hoffmann-La Roche 2017 Oncology Biosimilars Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.4.4 F Hoffmann-La Roche 2017 Oncology Biosimilars Business Region Distribution Analysis
8.5 Mylan
8.5.1 Company Profile
8.5.2 Product Picture and Specifications
8.5.2.1 Product A
8.5.2.2 Product B
8.5.3 Mylan 2017 Oncology Biosimilars Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.5.4 Mylan 2017 Oncology Biosimilars Business Region Distribution Analysis
8.6 Sandoz
8.6.1 Company Profile
8.6.2 Product Picture and Specifications
8.6.2.1 Product A
8.6.2.2 Product B
8.6.3 Sandoz 2017 Oncology Biosimilars Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.6.4 Sandoz 2017 Oncology Biosimilars Business Region Distribution Analysis

9 Development Trend of Analysis of Oncology Biosimilars Market
9.1 Global Oncology Biosimilars Market Trend Analysis
9.1.1 Global 2018-2025 Oncology Biosimilars Market Size (Volume and Value) Forecast
9.1.2 Global 2018-2025 Oncology Biosimilars Sales Price Forecast
9.2 Oncology Biosimilars Regional Market Trend
9.2.1 North America 2018-2025 Oncology Biosimilars Consumption Forecast
9.2.2 Europe 2018-2025 Oncology Biosimilars Consumption Forecast
9.2.3 China 2018-2025 Oncology Biosimilars Consumption Forecast
9.2.4 Japan 2018-2025 Oncology Biosimilars Consumption Forecast
9.2.5 Southeast Asia 2018-2025 Oncology Biosimilars Consumption Forecast
9.2.6 India 2018-2025 Oncology Biosimilars Consumption Forecast
9.3 Oncology Biosimilars Market Trend (Product Type)
9.4 Oncology Biosimilars Market Trend (Application)

10 Oncology Biosimilars Marketing Type Analysis
10.1 Oncology Biosimilars Regional Marketing Type Analysis
10.2 Oncology Biosimilars International Trade Type Analysis
10.3 Traders or Distributors with Contact Information of Oncology Biosimilars by Region
10.4 Oncology Biosimilars Supply Chain Analysis

11 Consumers Analysis of Oncology Biosimilars
11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis

12 Conclusion of the Global Oncology Biosimilars Market Professional Survey Report 2017
Methodology
Analyst Introduction
Data Source

List of Tables and Figures
Figure Picture of Oncology Biosimilars
Table Product Specifications of Oncology Biosimilars
Table Classification of Oncology Biosimilars
Figure Global Production Market Share of Oncology Biosimilars by Type in 2017
Figure Breast Cancer Picture
Table Major Manufacturers of Breast Cancer
Figure Blood Cancer Picture
Table Major Manufacturers of Blood Cancer
Figure Colorectal Cancer Picture
Table Major Manufacturers of Colorectal Cancer
Figure Non-Small Picture
Table Major Manufacturers of Non-Small
Figure Cell Lung Cancer Picture
Table Major Manufacturers of Cell Lung Cancer
Figure Neutropenia Picture
Table Major Manufacturers of Neutropenia
Figure Others Picture
Table Major Manufacturers of Others
Table Applications of Oncology Biosimilars
Figure Global Consumption Volume Market Share of Oncology Biosimilars by Application in 2017
Figure Retail Pharmacies Examples
Table Major Consumers in Retail Pharmacies
Figure Hospitals Examples
Table Major Consumers in Hospitals
Figure Market Share of Oncology Biosimilars by Regions
Figure North America Oncology Biosimilars Market Size (Million USD) (2013-2025)
Figure Europe Oncology Biosimilars Market Size (Million USD) (2013-2025)
Figure China Oncology Biosimilars Market Size (Million USD) (2013-2025)
Figure Japan Oncology Biosimilars Market Size (Million USD) (2013-2025)
Figure Southeast Asia Oncology Biosimilars Market Size (Million USD) (2013-2025)
Figure India Oncology Biosimilars Market Size (Million USD) (2013-2025)
Table Oncology Biosimilars Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Oncology Biosimilars in 2017
Figure Manufacturing Process Analysis of Oncology Biosimilars
Figure Industry Chain Structure of Oncology Biosimilars
Table Capacity and Commercial Production Date of Global Oncology Biosimilars Major Manufacturers in 2017
Table Manufacturing Plants Distribution of Global Oncology Biosimilars Major Manufacturers in 2017
Table R&D Status and Technology Source of Global Oncology Biosimilars Major Manufacturers in 2017
Table Raw Materials Sources Analysis of Global Oncology Biosimilars Major Manufacturers in 2017
Table Global Capacity, Sales , Price, Cost, Sales Revenue (M USD) and Gross Margin of Oncology Biosimilars 2013-2018E
Figure Global 2013-2018E Oncology Biosimilars Market Size (Volume) and Growth Rate
Figure Global 2013-2018E Oncology Biosimilars Market Size (Value) and Growth Rate
Table 2013-2018E Global Oncology Biosimilars Capacity and Growth Rate
Table 2017 Global Oncology Biosimilars Capacity (K MT) List (Company Segment)
Table 2013-2018E Global Oncology Biosimilars Sales (K MT) and Growth Rate
Table 2017 Global Oncology Biosimilars Sales (K MT) List (Company Segment)
Table 2013-2018E Global Oncology Biosimilars Sales Price (USD/MT)
Table 2017 Global Oncology Biosimilars Sales Price (USD/MT) List (Company Segment)
Figure North America Capacity Overview
Table North America Supply, Import, Export and Consumption (K MT) of Oncology Biosimilars 2013-2018E
Figure North America 2013-2018E Oncology Biosimilars Sales Price (USD/MT)
Figure North America 2017 Oncology Biosimilars Sales Market Share
Figure Europe Capacity Overview
Table Europe Supply, Import, Export and Consumption (K MT) of Oncology Biosimilars 2013-2018E
Figure Europe 2013-2018E Oncology Biosimilars Sales Price (USD/MT)
Figure Europe 2017 Oncology Biosimilars Sales Market Share
Figure China Capacity Overview
Table China Supply, Import, Export and Consumption (K MT) of Oncology Biosimilars 2013-2018E
Figure China 2013-2018E Oncology Biosimilars Sales Price (USD/MT)
Figure China 2017 Oncology Biosimilars Sales Market Share
Figure Japan Capacity Overview
Table Japan Supply, Import, Export and Consumption (K MT) of Oncology Biosimilars 2013-2018E
Figure Japan 2013-2018E Oncology Biosimilars Sales Price (USD/MT)
Figure Japan 2017 Oncology Biosimilars Sales Market Share
Figure Southeast Asia Capacity Overview
Table Southeast Asia Supply, Import, Export and Consumption (K MT) of Oncology Biosimilars 2013-2018E
Figure Southeast Asia 2013-2018E Oncology Biosimilars Sales Price (USD/MT)
Figure Southeast Asia 2017 Oncology Biosimilars Sales Market Share
Figure India Capacity Overview
Table India Supply, Import, Export and Consumption (K MT) of Oncology Biosimilars 2013-2018E
Figure India 2013-2018E Oncology Biosimilars Sales Price (USD/MT)
Figure India 2017 Oncology Biosimilars Sales Market Share
Table Global 2013-2018E Oncology Biosimilars Sales (K MT) by Type
Table Different Types Oncology Biosimilars Product Interview Price
Table Global 2013-2018E Oncology Biosimilars Sales (K MT) by Application
Table Different Application Oncology Biosimilars Product Interview Price
Table Biocon Information List
Table Product Overview
Table 2017 Biocon Oncology Biosimilars Revenue (Million USD), Sales (K MT), Ex-factory Price (USD/MT)
Figure 2017 Biocon Oncology Biosimilars Business Region Distribution
Table Celltrion Information List
Table Product Overview
Table 2017 Celltrion Oncology Biosimilars Revenue (Million USD), Sales (K MT), Ex-factory Price (USD/MT)
Figure 2017 Celltrion Oncology Biosimilars Business Region Distribution
Table Dr Reddy's Laboratories Information List
Table Product Overview
Table 2017 Dr Reddy's Laboratories Oncology Biosimilars Revenue (Million USD), Sales (K MT), Ex-factory Price (USD/MT)
Figure 2017 Dr Reddy's Laboratories Oncology Biosimilars Business Region Distribution
Table F Hoffmann-La Roche Information List
Table Product Overview
Table 2017 F Hoffmann-La Roche Oncology Biosimilars Revenue (Million USD), Sales (K MT), Ex-factory Price (USD/MT)
Figure 2017 F Hoffmann-La Roche Oncology Biosimilars Business Region Distribution
Table Mylan Information List
Table Product Overview
Table 2017 Mylan Oncology Biosimilars Revenue (Million USD), Sales (K MT), Ex-factory Price (USD/MT)
Figure 2017 Mylan Oncology Biosimilars Business Region Distribution
Table Sandoz Information List
Table Product Overview
Table 2017 Sandoz Oncology Biosimilars Revenue (Million USD), Sales (K MT), Ex-factory Price (USD/MT)
Figure 2017 Sandoz Oncology Biosimilars Business Region Distribution
Figure Global 2018-2025 Oncology Biosimilars Market Size (K MT) and Growth Rate Forecast
Figure Global 2018-2025 Oncology Biosimilars Market Size (Million USD) and Growth Rate Forecast
Figure Global 2018-2025 Oncology Biosimilars Sales Price (USD/MT) Forecast
Figure North America 2018-2025 Oncology Biosimilars Consumption Volume (K MT) and Growth Rate Forecast
Figure China 2018-2025 Oncology Biosimilars Consumption Volume (K MT) and Growth Rate Forecast
Figure Europe 2018-2025 Oncology Biosimilars Consumption Volume (K MT) and Growth Rate Forecast
Figure Southeast Asia 2018-2025 Oncology Biosimilars Consumption Volume (K MT) and Growth Rate Forecast
Figure Japan 2018-2025 Oncology Biosimilars Consumption Volume (K MT) and Growth Rate Forecast
Figure India 2018-2025 Oncology Biosimilars Consumption Volume (K MT) and Growth Rate Forecast
Table Global Sales Volume (K MT) of Oncology Biosimilars by Type 2018-2025
Table Global Consumption Volume (K MT) of Oncology Biosimilars by Application 2018-2025
Table Traders or Distributors with Contact Information of Oncology Biosimilars by Region

Choose License Type